[1]
L. G. Mantovani, P. A. Cortesi, A. Cardillo, L. Santoni, and L. Prosperini, “Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy”, FE, vol. 23, no. 1, Feb. 2022.